A open-label study of entecavir for chronic hepatitis B to determine the optimum duration of administratio
Phase 4
Completed
- Conditions
- chronic hepatitis B
- Registration Number
- JPRN-UMIN000000644
- Lead Sponsor
- Gunma Liver Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1. During pregnancy and the possibility of pregnancy 2. Participating in the other clinical trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The recurrence rate after completing Entecavir administration, the rate of loss of serum HBV-DNA, the rate of improvement of transaminase, the rate of HBeAg seroconversion
- Secondary Outcome Measures
Name Time Method